AMGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 270 USD | +0.22% |
|
+0.39% | -6.26% |
| 04-26 | Amgen to Submit Thyroid Eye Disease Treatment Marketing Authorization Application in Europe | MT |
| 04-26 | Amgen to Seek European OK of Thyroid Eye Disease Drug Tepezza | DJ |
Chart calendar Amgen Inc.
45794e04b.yBT5uPCJHf10OdVjsuH-MghvxJjz2Saza6mQC6vtU0w.5WCJyb7OWMQMQYoV4qLMAGAOvqm3uF_GD5z7Ju7ZP3WdU6mAgMZ6vitW5Q~6b3bb2f7d3a78aaa7df9e84f8aeaf002
Upcoming events on Amgen Inc.
Past events on Amgen Inc.
| 10/03/2024 00:50 | American Academy of Dermatology Meeting |
| 10/03/2024 00:15 | American Academy of Dermatology Meeting - Abstracts No - #51067 |
| 09/03/2024 23:55 | American Academy of Dermatology Meeting - Abstracts No - #50668 |
| 09/03/2024 17:20 | American Academy of Dermatology Meeting |
| 07/03/2024 | American Academy of Dermatology Meeting - Abstracts No - #50233 |
| 07/03/2024 | American Academy of Dermatology Meeting - Abstracts No - #52846 |
| 07/03/2024 | American Academy of Dermatology Meeting - Abstracts No - #51480 |
| 07/03/2024 | American Academy of Dermatology Meeting - Abstracts No - #51246 |
| 05/03/2024 14:10 | TD Cowen Health Care Conference |
| 22/02/2024 21:00 | Business Update Call |
| 14/02/2024 | Ex-dividend day |
| 14/02/2024 17:00 | Oppenheimer Healthcare Life Sciences Conference |
| 06/02/2024 21:30 | Q4 2023 Earnings Call |
| 06/02/2024 21:01 | Q4 2023 Earnings Release |
| 08/01/2024 17:00 | JPMorgan Healthcare Conference |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Abstract No: 4092 |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Abstract #4092 |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Abstract No: 4705 |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Abstract No: 4245 |
| 12/12/2023 02:00 | American Society of Hematology Meeting - Abstract No: 4249 |
Past dividends on Amgen Inc.
| 14/02/2024 | Quarterly 2.25 USD |
| 15/11/2023 | Quarterly 2.13 USD |
| 16/08/2023 | Quarterly 2.13 USD |
| 16/05/2023 | Quarterly 2.13 USD |
| 13/02/2023 | Quarterly 2.13 USD |
| 15/11/2022 | Quarterly 1.94 USD |
| 16/08/2022 | Quarterly 1.94 USD |
| 15/05/2022 | Quarterly 1.94 USD |
| 13/02/2022 | Quarterly 1.94 USD |
| 14/11/2021 | Quarterly 1.76 USD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 23 362 23 196 0.71% | 25 424 25 363 0.24% | 25 979 25 999 -0.08% | 26 323 26 247 0.29% | 28 190 28 108 0.29% | 32 952 |
|
EBITDA Million USD | Released Forecast Spread | 13 363 13 029 2.56% | 15 935 15 167 5.06% | 15 822 16 002 -1.12% | 16 178 15 935 1.53% | 17 470 16 351 6.84% | 19 321 |
|
EBIT Million USD | Released Forecast Spread | 11 157 11 138 0.17% | 12 334 12 315 0.15% | 12 424 12 479 -0.44% | 12 761 12 728 0.26% | 13 399 13 423 -0.18% | 15 074 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 9 138 9 499 -3.8% | 8 133 8 782 -7.39% | 6 701 6 379 5.04% | 7 346 7 466 -1.6% | 7 855 8 859 -11.33% | 6 554 |
|
Net income Million USD | Released Forecast Spread | 7 842 7 850 -0.1% | 7 264 7 163 1.41% | 5 893 5 598 5.27% | 6 552 6 525 0.41% | 6 717 7 401 -9.24% | 6 114 |
|
EPS USD | Released Forecast Spread | 12,9 12,8 0.4% | 12,3 12,0 2.4% | 10,3 9,84 4.5% | 12,1 12,1 0.41% | 12,5 13,8 -9.66% | 11,5 |
| Announcement Date | 30/01/20 | 02/02/21 | 07/02/22 | 31/01/23 | 06/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 6 846 6 869 -0.34% | 6 238 6 111 2.08% | 6 594 6 526 1.04% | 6 652 6 556 1.47% | 6 839 6 766 1.08% | 6 105 6 177 -1.17% | 6 986 6 680 4.58% | 6 903 6 948 -0.65% | 8 196 8 106 1.11% | 7 453 | 8 312 | 8 425 | 8 804 | 7 911 |
|
EBITDA Million USD | Released Forecast Spread | 3 849 3 952 -2.62% | 3 981 3 747 6.24% | 4 163 3 953 5.31% | 4 114 4 068 1.13% | 3 920 3 744 4.7% | 3 721 3 684 1.01% | 4 411 4 152 6.25% | 4 298 4 443 -3.25% | 5 040 4 568 10.32% | 4 373 | 5 114 | 5 264 | 5 352 | |
|
EBIT Million USD | Released Forecast Spread | 2 997 3 070 -2.37% | 3 140 2 939 6.84% | 3 335 3 152 5.8% | 3 277 3 201 2.39% | 3 009 2 976 1.11% | 2 821 2 879 -2.01% | 3 515 3 292 6.77% | 3 403 3 424 -0.62% | 3 660 3 689 -0.78% | 3 164 | 3 887 | 3 993 | 4 030 | 3 776 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 2 131 1 944 9.62% | 1 675 2 243 -25.32% | 1 531 2 046 -25.18% | 2 392 2 021 18.36% | 1 748 1 866 -6.32% | 3 442 2 294 50.04% | 1 614 2 402 -32.81% | 1 947 2 183 -10.81% | 852 1 517 -43.85% | 1 214 | 1 780 | 1 790 | 1 011 | 2 995 |
|
Net income Million USD | Released Forecast Spread | 1 899 1 654 14.82% | 1 476 1 725 -14.42% | 1 317 1 749 -24.72% | 2 143 1 665 28.68% | 1 616 1 686 -4.16% | 2 841 1 479 92.11% | 1 379 1 840 -25.04% | 1 730 1 772 -2.38% | 767 1 308 -41.36% | 1 127 | 1 701 | 1 831 | 1 563 | 2 019 |
|
EPS USD | Released Forecast Spread | 3,36 3,01 11.45% | 2,68 3,24 -17.27% | 2,45 3,28 -25.3% | 3,98 3,06 30.15% | 3,00 3,21 -6.6% | 5,28 2,98 77.12% | 2,57 3,40 -24.34% | 3,22 3,29 -2.1% | 1,42 2,36 -39.72% | 2,71 | 3,25 | 3,60 | 2,97 | 3,78 |
| Announcement Date | 07/02/22 | 27/04/22 | 04/08/22 | 03/11/22 | 31/01/23 | 27/04/23 | 03/08/23 | 31/10/23 | 06/02/24 | - | - | - | - | - |
More events
Past sector events for Amgen Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AMGN Stock
- Calendar Amgen Inc.
